Aripiprazole Augmentation Treatment in Treatment Resistant Bipolar Depression: Two Patient Reports

Basit Öğe Kaydı
dc.contributor.authorKaradag, Figen
dc.contributor.authorTan, Devran
dc.contributor.authorUnal, Feyza
dc.date.accessioned2024-07-12T21:53:56Z
dc.date.available2024-07-12T21:53:56Z
dc.date.issued2011en_US
dc.departmentMaltepe Üniversitesien_US
dc.description.abstractIt is known that in patients with bipolar disorder, depressive episodes last longer than mixed or manic/hypomanic episodes and there are reports detailing the difficulties confronted in its treatment. The concept of treatment resistant depression in bipolar disorder has not been as well described as that in treatment resistant unipolar depression. Here we present two patients with treatment resistant bipolar depression. The first patient in our study is a 51 year old woman whose diagnoses were bipolar disorder, depressive episode and multiple sclerosis (in remission with interferon treatment) at the time of augmentation with aripiprazole. The second patient is a 43 year old woman with bipolar disorder, depressive disorder without any comorbid illness at the time of augmentation with aripiprazole. Aripiprazole was administered variably between 20-30mg/daily based on tolerability and efficacy,. In both cases, depression was assessed using the Hamilton Depression Rating scale (HDRS). Both patients responded to aripiprazole augmentation treatment. The effect of aripiprazole on bipolar depression needs to be further evaluated in double blind controlled studies. However, augmentation with aripiprazole in bipolar patients may be a future routine treatment for treatment resistant bipolar depression. In this report, treatment of refractory bipolar depression and the efficacy of aripiprazole augmentation treatment in bipolar depression are discussed through two patients in depressive episode who remitted with aripiprazole augmentationen_US
dc.identifier.endpage272en_US
dc.identifier.issn1300-2163
dc.identifier.issue4en_US
dc.identifier.pmid22143953en_US
dc.identifier.scopus2-s2.0-84861167311en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage269en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/8552
dc.identifier.volume22en_US
dc.identifier.wosWOS:000299187000010en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotren_US
dc.publisherTURKIYE SINIR VE RUH SAGLIGI DERNEGIen_US
dc.relation.ispartofTURK PSIKIYATRI DERGISIen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY03673
dc.subjectBipolar depressionen_US
dc.subjecttreatment resistanten_US
dc.subjectaripiprazoleen_US
dc.subjectaugmentationen_US
dc.titleAripiprazole Augmentation Treatment in Treatment Resistant Bipolar Depression: Two Patient Reportsen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu